SODIUM LABELING, PEDIATRIC DOSING FOR COUGH/COLD PRODUCTS ARE POTENTIAL FUTURE TOPICS FOR OTC ADVISORY CMTE., FDA’s BOTSTEIN SAYS; DOXYLAMINE ISSUE ALSO CITED

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".